InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Bernhardt G Zeiher
20 May 2026
Director
Buy indirect
5,000
$5.86
$29.32K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
13,082
$9.07
$118.69K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
1,186
$9.07
$10.76K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
13,386
$9.07
$121.39K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
1,213
$9.07
$11.00K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
11,494
$7.95
$91.43K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
1,040
$7.95
$8.27K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
80,881
$7.73
$625.33K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
7,321
$7.73
$56.60K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
30,879
$7.54
$232.81K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
2,795
$7.54
$21.07K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
11,701
$7.39
$86.48K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
1,059
$7.39
$7.83K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
2,947
$7.22
$21.29K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
267
$7.22
$1.93K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
25,364
$7.21
$182.97K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
2,296
$7.21
$16.56K
Show all 61 transactions →

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 1
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 396,101
History held since 1 Nov 2021